专利号:EP-3103803-B1 优先权日:2008-10-27 标 题 :Intermediates for the synthesis of mtor kinase inhibitors
专利号:EP-3660020-A1 优先权日:2008-10-27 标题 :Process for the synthesis of mtor kinase inhibitors
专利号:EP-3103803-A1 优先权日:2008-10-27 标 题 :Intermediates for the synthesis of mtor kinase inhibitors
专利号:EP-3660020-B1 优先权日:2008-10-27 标题:Process for the synthesis of mtor kinase inhibitors
专利号:US-2006205787-A1 优先权日:2005-01-25 标题 :Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1,3-dione 发明人:MULLER GEORGE W; CHEN ROGER S 权利人:MULLER GEORGE W; CHEN ROGER S 摘要:This invention relates to racemic and stereomerically pure 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1,3-dione, and prodrugs, salts and solvates thereof. Synthesis, methods of use, and pharmaceutical compositions of racemic and stereomerically pure 4-amino-2-(3-methyl-2,6-dioxo-piperidine-3-yl)-isoindole-1,3-dione, and prodrugs, salts and solvates thereof, are disclosed.
专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
1: Liu HX, Liu CF, Yang WH. Clinical study of continuous micropump infusion of atropine and pralidoxime chloride for treatment of severe acute organophosphorus insecticide poisoning. J Chin Med Assoc. 2015 Dec;78(12):709-13. doi: 10.1016/j.jcma.2015.08.006. Epub 2015 Oct 3. doi: 10.1016/j.ejps.2014.01.013. Epub 2014 Feb 14. doi: 10.1093/toxsci/kft337. Epub 2014 Jan 2. doi: 10.1016/j.ajem.2013.08.052. Epub 2013 Oct 1. doi: 10.1093/toxsci/kft217. Epub 2013 Sep 19. 7: Banerjee S, Chattopadhyay P, Ghosh A, Kaity S, Veer V. Development and validation of a reverse phase liquid chromatography method for the simultaneous quantification of eserine and pralidoxime chloride in drugs-in-adhesive matrix type transdermal patches. Drug Res (Stuttg). 2013 Sep;63(9):450-6. doi: 10.1055/s-0033-1343471. Epub 2013 Apr 30. doi: 10.1016/j.ajem.2013.03.012. Epub 2013 May 14. doi: 10.1016/j.lfs.2011.09.019. Epub 2011 Oct 4. Chinese. Chinese. 14: Karljiković-Rajić K, Stanković B. Potentiometric investigation of the stability of palladium(II) complex of pralidoxime chloride in aqueous solution. J Pharm Biomed Anal. 1990;8(8-12):705-9.